EC Number | Cloned (Comment) | Organism |
---|---|---|
1.6.99.1 | expression of N-terminally His6-tagged enzyme in Escherichia coli strain BL21(DE3) | Trypanosoma cruzi |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.6.99.1 | purified enzyme, hanging drop vapor diffusion method, mixing of 0.002 ml of protein solution containing 14 mg/mL in 25 mM Tris-HCl, pH 8.0, containing 100 mM NaCl, and 1 mM 2-mercaptoethanol, with 0002 ml of 28% w/v PEG 1500, and 0.3 M ammonium fluoride, equilibration against 0.5 ml of reservoir solution, 19°C, 10 days, crystalline forms I and II, X-ray diffraction structure determination and analysis at 1.27 A and 2.0 A resolution, respectively | Trypanosoma cruzi |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.6.99.1 | additional information | Trypanosoma cruzi | analysis of binding mode of beta-lapachone, a trypanocidal agent, and other naphthoquinones by molecular docking and dynamics: their binding to TcOYE is stabilized mainly by interactions with the isoalloxazine ring from FMN and residues from the active-site pocket | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.100 | Aspergillus fumigatus | - |
- |
- |
1.3.1.100 | Aspergillus fumigatus FGSC A1141 | - |
- |
- |
1.6.99.1 | Trypanosoma cruzi | Q2TJB8 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.6.99.1 | recombinant N-terminally His6-tagged enzyme from Escherichia coli strain BL21(DE3) by affinity chromatography | Trypanosoma cruzi |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.6.99.1 | additional information | analysis of binding mode of beta-lapachone, a trypanocidal agent, and other naphthoquinones by molecular docking and dynamics: their binding to TcOYE is stabilized mainly by interactions with the isoalloxazine ring from FMN and residues from the active-site pocket | Trypanosoma cruzi | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.6.99.1 | monomer | TcOYE behaves as a globular monomer in solution | Trypanosoma cruzi |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.100 | EasA | - |
Aspergillus fumigatus |
1.6.99.1 | old yellow enzyme | - |
Trypanosoma cruzi |
1.6.99.1 | OYE | - |
Trypanosoma cruzi |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.100 | NADP+ | - |
Aspergillus fumigatus | |
1.6.99.1 | FMN | prosthetic group, detailed binding mode, overview. TcOYE displays a canonical (alpha/bet)8-barrel fold with a FMN prosthetic group located at the large active-site cavity | Trypanosoma cruzi |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.3.1.100 | malfunction | disruption of the easA gene leads to accumulation of chanoclavine-I and chanoclavine-I-aldehyde | Aspergillus fumigatus |
1.3.1.100 | metabolism | the enzyme is required for incorporation of chanoclavine-I-aldehyde into more-complex ergot alkaloids, presumably by reducing the double bond conjugated to the aldehyde group, thus facilitating ring closure | Aspergillus fumigatus |
1.6.99.1 | additional information | the enzyme shows a classical (alpha/beta)8 fold with the FMN prosthetic group buried at the positively-charged active-site cleft. In solution, TcOYE behaves as a globular monomer, but it exhibits a molecular envelope larger than that observed in the crystal structure, suggesting intrinsic protein flexibility. TcOYE also possesses characteristic extra barrel elements, including (i) the N-terminal beta-hairpin (residues 10-19) that closes the bottom of the barrel, (ii) the capping subdomain (105-164), which participates in the formation of the large active-site pocket, (iii) the alpha-helical motif (196-222) related to substrate recognition, and (iv) the inner allpha-helix (336-341) that contributes to FMN binding | Trypanosoma cruzi |
1.6.99.1 | physiological function | the enzyme is clinically relevant due to its role in the action mechanism of some trypanocidal drugs used in the treatment of Chagas' disease by producing reactive oxygen species | Trypanosoma cruzi |